Chronic Lymphocytic Leukemia Clinical Trials

ReadTheTrial indexes 3 studies for Chronic Lymphocytic Leukemia. The most common development stage is Phase 3 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Chronic Lymphocytic Leukemia.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 2
67%
N/A 1
33%

Trial Status Breakdown

Trials for Chronic Lymphocytic Leukemia

Determinants of the Response to BTK Degraders (BTKd) in Double Refractory Chronic Lymphocytic Leukemia (CLL)

NCT07099443 · RECRUITING · N/A

Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

NCT04269902 · RECRUITING · Phase 3

A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)

NCT03737981 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Chronic Lymphocytic Leukemia?

There are 3 clinical trials listed for Chronic Lymphocytic Leukemia. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Chronic Lymphocytic Leukemia trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Chronic Lymphocytic Leukemia trials in?

Current Chronic Lymphocytic Leukemia trials are distributed across: Phase 3 (2), N/A (1).

Find More Trials